Frias et al., The Lancet, 2021 (SURPASS-2) Targets Two Key Aging Pathways By activating both GLP-1 and GIP pathways, Tirzepatide offers a more comprehensive approach to reversing metabolic aging compared to single-agonist therapies
C., Lin, J
P, 68 years old, was diagnosed with Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's Disease) five years ago
Learn More about Vein Treatment (Sclerotherapy) Cosmetic Services Consultation-first cosmetic care for wrinkles, texture, pigmentation, volume loss, and skin laxity with realistic treatment planning
GHK-Cu replenishes the copper tripeptide your client's body naturally loses with age rebuilding collagen in skin and reactivating dormant follicles in the scalp, all from one professional serum